Clinical Trial: A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814651) titled 'A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly' on Sept. 07.

Brief Summary: This trial is a phase II clinical trial to evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of octreotide long-acting injection in patients with acromegaly.

Study Start Date: April 16, 2024

Study Type: INTERVENTIONAL

Condition: Acromegaly

Intervention: DRUG: SYHX2008

The patients will accept SYHX2008 injection by subcutaneous administration.A treatment period of 12 weeks.

DRUG: Sandostatin LAR

The patients will accept Sandostatin ...